β3 integrin expression in melanoma predicts subsequent metastasis

Journal of Surgical Research

Volumn 63, Issue 1, 1996, Pages 169-173

  Hieken, Tina J ^a,b   Farolan, Miguel ^a   Ronan, Salve G ^a   Shilkaitis, Anne ^a   Wild, Linda ^a   Das Gupta, Tapas K ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Department of Surgical Oncology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; INTEGRIN; UNCLASSIFIED DRUG; FIBRINOGEN RECEPTOR; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS POTENTIAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; IMMUNOLOGY; METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SKIN TUMOR; SURVIVAL RATE; TIME;

ANTIGENS, CD; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA3; MELANOMA; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PLATELET MEMBRANE GLYCOPROTEINS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 0029665802     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0242     Document Type: Conference Paper

References (41)

1. Brozena, S. J., Fenske, N. A., and Perez, I. R. Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors. Semin. Surg. Oncol. 9: 165, 1993.
2. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin. 45: 8, 1995.
3. Das Gupta, T., and Brasfield, R. Metastatic melanoma: A clinicopathological study. Cancer 17: 1323, 1964.
4. Ronan, S. G., Han, M. C., and Das Gupta, T. K. Histologic prognostic indicators in cutaneous malignant melanoma. Semin. Oncol. 15: 558, 1988.
5. Barth, A., Wanek, L. A., and Morton, D. L. Prognostic factors in 1,521 melanoma patients with distant metastases. J. Am. Coll. Surg. 181: 193, 1995.
6. 3 subunit with tumor progression. Cancer Res. 50: 6757, 1990.
7. Cheresh, D. A. Structure, function and biological properties of integrin αvβ3 on human melanoma cells. Cancer Metastasis Rev. 10: 3, 1991.
8. Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., and Cheresh, D. A. Involvement of integrin av gene expression in human melanoma tumorigenicity. J. Clin. Invest. 89: 2018, 1992.
9. Gehlsen, K. R., Davis, G. E., and Sriramarao, P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin. Exp. Metastasis 10: 111, 1992.
10. Supino, R., Mapelli, E., Sanfilippo, O., and Silvestro, L. Biological and enzymatic features of human melanoma clones with different invasive potential. Melanoma Res. 2: 377, 1992.
11. Vink, J., Thomas, L., Etoh, T., et al. Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro. Lab. Invest. 68: 192, 1993.
12. Timar, J., Baraz, R., Kimler, V., Haddad, M., et al. Immunomorphological characterization and effects of 12-(S)-HETE on a dynamic intracellular pool of the αIIbβ3 integrin in melanoma cells. J. Cell Sci. 108: 2175, 1995.
13. 1 integrins during human melanoma cell invasion. Cancer Res. 53: 3411, 1993.
14. Moretti, S., Martini, L., Berti, E., Pinzi, C., and Giannotti, B. Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res. 3: 235, 1993.
15. Schadendorf, D., Gawlik, C., Haney, U., Ostmeier, H., Suter, L., and Czarnetzki, B. M. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumors. J. Pathol. 170: 429, 1993.
16. 3 vitronectin-receptor expression in melanocytic tumor progression. Histopathology 24: 249, 1994.
17. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157, 1994.
18. Hieken, T. J., Ronan, S. G., Farolan, M., Shilkaitis, A. L., Kim, D. K., and Das Gupta, T. K. Betal integrin expression in malignant melanoma predicts occult lymph node metastases. Surgery 118: 669, 1995.
19. Scott, G., and Liang, H. pp125FAK in human melanocytes and melanoma: Expression and phosphorylation. Exp. Cell Res. 219(1): 197, 1995.
20. Filardo, E. J., Brooks, P. C., Deming, S. L., Damsky, C., and Cheresh, D. A. Requirement of NPXY motif in the integrin β3 cytoplasmic tail for melanoma cell migration in vitro and in vivo. J. Cell Biol. 130: 441, 1995.
21. Ruoslahti, E., and Pierschbacher, M. D. New perspectives in cell adhesion: RGD and integrins. Science 238: 491, 1987.
22. Hynes, R. O. Integrins: Versatility, modulation and signaling in cell adhesion. Cell 69: 11, 1992.
23. Arroyo, A. G., Garcia-Pardo, A., and Sanchez-Madrid, F. A high affinity conformational state on VLA integrin heterodimers induced by an anti-β1 chain monoclonal antibody. J. Biol. Chem. 268(13): 9863, 1993.
24. Miyamoto, S., Akiyama, S. K., and Yamada, K. M. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267: 883, 1995.
25. Clark, E. A., and Brugge, J. S. Integrins and signal transduction pathways: The road taken. Science 268: 233, 1995.
26. Smith, J. W., and Cheresh, D. A. Integrin αvβ3-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor. J. Biol. Chem. 265: 2168, 1990.
27. Aznavoorian, S., Murphy, A. N., Stetler-Stevenson, W. G., and Liotta, L. A. Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368, 1993.
28. 3 for angiogenesis. Science 264: 569, 1994.
29. Orlando, R. A., and Cheresh, D. A. Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin αvβ3 and its ligand. J. Biol. Chem. 266: 19543, 1991.
30. Hart, I. R., Birch, M., and Marshall, J. F. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev. 10: 115, 1991.
31. Hardan, I., Weiss, L., Hershkoviz, R., et al. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic arg-gly-asp mimetics. Int. J. Cancer 55: 1023, 1993.
32. Seftor, R. E., Seftor, E. A., Gehlsen, K. R., Stetler-Stevenson, W. B., et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc. Natl. Acad. Sci. USA 89(5): 1557, 1992.
33. Nip, J., Rabbani, S. A., Shibata, H., and Brodt, P. Coordinated expression of the vitronectin receptor αvβ3 and urokinase-type plasminogen activator receptor in metastatic melanoma cells. Proc. Am. Assoc. Cancer. Res. 36: 66, 1995. [Abstract]
34. 3 to adhere to lymph node vitronectin. J. Clin. Invest. 90: 1406, 1992.
35. Montgomery, A. M., Reisfeld, R. A., and Cheresh, D. A. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collage. Proc. Natl. Acad. Sci. USA 91(10): 8856, 1994.
36. Mortarini, R., Gismondi, A., Maggioni, A., et al. Mitogenic activity of laminin on human melanoma and melanocytes: Different signal requirements and role of β1 integrins. Cancer Res. 55: 4702, 1995.
37. Filardo, E. J., and Cheresh, D. A. A beta turn in the cytoplasmic tail of the integrin av subunit influences conformation and ligand binding of αvβ3. J. Biol. Chem. 269: 4641, 1994.
38. Dumont, J. A., and Bitonti, A. J. Modulation of human melanoma cell metastasis and adhesion may involve integrin phosphorylation mediated through protein kinase C. Biochem. Biophys. Res. Commun. 204(1): 264, 1994.
39. 3 integrin: A posttranscriptional, protein kinase C- and cytoskeleton-dependent process. Cancer Res. 54: 1119, 1994.
40. Li, C., Ross, F. P., Cao, X., and Teitelbaum, S. L. Estrogen enhances αvβ3 integrin expression by avian osteoclast precursors via stabilization of β3 integrin mRNA. Mol. Endocrinol. 9: 805, 1995.
41. Gladson, C. L., and Cheresh, D. A. Glioblastoma expression of vitronectin and the αvβ3 integrin: Adhesion mechanism for transformed glial cells. J. Clin. Invest. 88: 1924, 1991.